Eferi Tablet 50 mg (Eperison Hydrochloride)

Adult dose

Administered orally as Eperison Hydrochloride, 50 mg three times a day after meals. Adjust dosage appropriately based on age and symptoms.

This medication should not be used in individuals with allergic reactions. It is also safe not to administer to patients with myasthenia gravis. Since this medication contains lactose, patients with genetic disorders affecting lactose digestion should avoid taking it. Patients with a history of hypersensitivity to medications should use this medication cautiously. Patients with liver dysfunction should be cautious as this medication may worsen liver function. Rarely, shock reactions may occur during treatment, so symptoms should be carefully monitored. Liver abnormalities, such as elevated liver enzyme levels, may manifest, requiring close observation. Since this medication may affect kidney function, any renal abnormal symptoms should be promptly reported. Symptoms of blood abnormalities, like anemia, may also rarely occur, so the condition should be monitored. Skin reactions like rash or itchiness may occur. Neurological symptoms, such as insomnia, drowsiness, headache, and limb paralysis, may manifest. Gastrointestinal issues like nausea, vomiting, loss of appetite, and abdominal pain may also appear. Urological problems such as urinary retention, incontinence, and residual urine sensations may occur, requiring caution. General symptoms like weakness, dizziness, and reduced muscle tension may also arise. Symptoms like facial flushing, sweating, and swelling may also rarely occur. Severe allergic reactions such as anaphylaxis may occur, requiring immediate notification to healthcare professionals in case of abnormal symptoms. Serious skin reactions like toxic epidermal necrolysis and mucocutaneous-ocular syndrome (Stevens-Johnson syndrome) may present, so careful observation of skin symptoms is necessary. If weakness, staggering, or drowsiness arise during this medication, dosage adjustment or discontinuation should be considered. Since drowsiness and decreased concentration can occur, it is advisable to avoid driving or operating hazardous machinery. Caution is warranted when using this medication with similar drugs as coordination disturbances may appear. Safety during pregnancy has not been established, so administration must be discussed with a doctor. During breastfeeding, it is advisable to avoid administration or, if unavoidable, to stop breastfeeding. Safety in children has not been sufficiently confirmed, so it should be used cautiously. Elderly patients may have reduced bodily functions, so dosages should be adjusted, and careful administration is required. Store out of reach of children and avoid transferring to other containers.

Serious side effects

Shock, liver dysfunction (elevated ALT, AST, ALP), kidney dysfunction (proteinuria, elevated BUN), anemia, anaphylaxis, angioedema, toxic epidermal necrolysis and mucocutaneous-ocular syndrome (Stevens-Johnson syndrome)

Mild side effects

• Rash
• itching
• insomnia
• drowsiness
• headache
• body stiffness
• limb tremors
• nausea
• vomiting
• loss of appetite

This medication should be stored in a tightly sealed container to prevent air exposure, ideally at a temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the medication's effectiveness and prevents deterioration.

Appearance

White round sugar-coated tablet

Package unit

30 tablets/bottle - 30 tablets/bottle, 100 tablets/bottle - 100 tablets/bottle, 500 tablets/bottle - 500 tablets/bottle, 1000 tablets/bottle - 1000 tablets/bottle, 100 tablets (10 tablets/PTP x 10) - 100 tablets/PTP[100 tablets (10 tablets/PTP x 10)]